2021-01-04,b'Most Volatile 12/31\n$SKLZ\n$XL\n$LEDS\n$NTEC\n$FLNT\n$AMS\n$RIOT\n$CLSK\n$IDYA\n$NK\n$TMDI\n$CPSH\n$NETE\n$BTU\n$SYRS\n$ELYS\n$SYPR\n$BTN\n$HYFM\n$SRGA\n$ATNF\n$OTRK\n$CNET\n$NXTC\n$NH\n$KRON\n$STON\n$NTIP\n$ONVO\n$PLAG\n$UPST\n$IGC\n$TUSK\n$IRIX\n$TCCO\n$OXBR\n$FUTU\n$KNTE\n$AVID\n$SLDB\n$OTIC\n$PRT\n$PRCH\n$TCON\n$SQFT'
2021-01-02,b'2/2\n\n$INBX $KNTE $KURA $MRSN $NKTX $NRIX $OLMA $ONCT $PASG $PMVP $PRLD $PTGX $RPTX $RCKT $SRRK $MCRB $SGTX $SBTX \n\nIf you\xe2\x80\x99re an expert in the field and see something you dont like please DM me.'
2021-01-02,b'$BEAM\n$NTLA\n$STOK\n$DCCC\n$NRIX\n$KYMR\n$FDMT\n$KNTE\n$BDTX\n$ITOS\n$MORF\n$TSHA\n$GBIO\n$FREQ\n$ORIC\n$DNLI\n$RPTX\n$PHAT?\n$SBTX\n$AVIR\n$PMVP\n$PRLD\n\nAn early list of bloated stocks that could fit this category. No position'
2021-01-01,b'RT @semodough: $KNTE Catalysts: submit IND and initiate Phase 1 study for KIN002787 (1H21); 2) Phase 1 safety data update (1H22); 3) comple\xe2\x80\xa6'
2021-01-01,b'RT @semodough: $KNTE Catalysts: submit IND and initiate Phase 1 study for KIN002787 (1H21); 2) Phase 1 safety data update (1H22); 3) comple\xe2\x80\xa6'
2021-01-01,"b""@PaulieVal @CathieDWood @ARKInvest @BioStocks @Kevin_M_Biotech @Biotech2050 @Biotech_SD One other thing I didn't mention in the realm of genetics of cancer is the Transduction Pathway companies. I have had 4 of them get bought out the past 3 years. They target the genetic mutations of cancer like $BPMC, $TPTX, $MRTX and $KNTE. There are many others if interested."""
2021-01-01,b'$KNTE slides https://t.co/t9ZZ7c2r10 https://t.co/ezak4KU1nU https://t.co/oTP4nSqpYe'
2021-01-01,b'$KNTE Catalysts: submit IND and initiate Phase 1 study for KIN002787 (1H21); 2) Phase 1 safety data update (1H22); 3) complete GLP tox for KIN003 (1H21); 4) submit IND &amp; initiate Phase 1 study for KIN003 (2H21/1H22); 5) Phase 1 safety data update for KIN003 (2H22)'
2021-01-01,b'RT @ProfitTradeRoom: \xf0\x9f\x94\xa5HOT\xf0\x9f\x94\xa5 stocks today\n$EVK $NSCO $TGA $AMTX $RAVE $LIZI $MFGP $ERJ $GSM $BA $FTEK $FCEL $KBSF $KNTE $ITRM $CIDM $INO $CLR\xe2\x80\xa6'
2021-01-01,b'W actionable: $SE $MRVL $AVGO $ASAN $AVTR $BBIO $BMRN $DMYD $FTCH $KPTI $LI $LSPD $ONEM $PFPT $RPRX $NFLX $NIO $MU $NTES \nOutside W + D setups: $CARR $KNTE $ONE $TME $NFLX \nInside W + D setups: $ISRG $PAYC $VRTX $BMRN $STLD \n#TrustTheProcess https://t.co/Adljxy4DHP'
2020-12-31,"b""RT @SwingTradeBot: Rose Above Previous Day's High today: $SNPS $FMB $SUSB $BIMI $BWFG $ITI $GOVT $GXG $GOED $MCBC $GTLS $CDTX $APTO $TLT $N\xe2\x80\xa6"""
2020-12-31,b'$KNTE $SQZ $OLMA Biotech IPO Frenzy Brings in 3 Stocks to Buy https://t.co/cpIJDBWTNU'
2020-12-31,b'Biotech IPO Frenzy Brings in 3 Stocks to Buy\n\n1. Kinnate Biopharma $KNTE\n2. SQZ Biotechnologies $SQZ\n3. Olema Pharmaceuticals $OLMA\n\n$IBB $XBI #stocks #investing #Biotechnology #trading https://t.co/taXH93FTBW'
2020-12-31,b'Scan results - Hot IPO Pullback today: $WISH $CNXC $OZON $KNTE $CERT $MASS $UPST $YQ $AIRC $WNW $SCPS ... https://t.co/0uY8IrkrWB'
2020-12-31,b'Biotech IPO Frenzy Brings in 3 Stocks to Buy https://t.co/lvNkcPmm3k $KNTE $SQZ $OLMA'
2020-12-31,"b""Rose Above Previous Day's High today: $SNPS $FMB $SUSB $BIMI $BWFG $ITI $GOVT $GXG $GOED $MCBC $GTLS $CDTX $APTO $TLT $NAC $HYLS $CTO $DSPG $PFBC $KNTE ... https://t.co/TBYRpvrFqi"""
2020-12-31,"b'RT @art_isit: Gainers Today:  $ONCT, $LPTX, $MYOV, $KNTE, $SQFT, $IPOC.  So many others are in RED\nCongrats to those who gain, and hope nex\xe2\x80\xa6'"
2020-12-31,"b'Gainers Today:  $ONCT, $LPTX, $MYOV, $KNTE, $SQFT, $IPOC.  So many others are in RED\nCongrats to those who gain, and hope next year will be better.\nHappy New Year Everyone! https://t.co/l7uM9BjckQ'"
2020-12-30,b'Scan results - Hot IPO Pullback today: $WISH $MRVI $MASS $ABCL $CERT $CNXC $KNTE $BCAB $UPST $YQ $SCPS $WNW ... https://t.co/qAAYCz0sxU'
2020-12-30,b'$KNTE is on my radar'
2020-12-30,"b'Wall Street\xe2\x80\x99s Key Stock Analysts Research Report, All Buys\n\nstocks\xc2\xa0#bullish #buys #analysts #research #WallStreet $ATVI $ATUS $KNTE $RMR $RKT These are all Buys if you can manage the risk. Daily\xc2\xa0HeffX-LTN reviews dozens of\xc2\xa0Wall Street\xe2\x80\x99s Key analysts\xc2\xa0rese\xe2\x80\xa6 https://t.co/uAiBAQyJnz'"
2020-12-29,b'RT @Biotech2k1: Started a small position in $KNTE. It has very interesting science around BRAF and FGFR. Its a bit more expensive from my v\xe2\x80\xa6'
2020-12-29,"b'Started a small position in $KNTE. It has very interesting science around BRAF and FGFR. Its a bit more expensive from my value model, but so much cheaper then the bubbly KRAS companies like $RVMD, $RLAY or $SDGR.'"
2020-12-29,"b""$KNTE's lead targeted oncology treatment enters phase 1 in 2021. Rising demand and regulatory pathways to approval could create continued growth for the company. We rate $KNTE at outperform with a 12-month target of $48. Explore our research process."""
2020-12-29,"b'Tuesday Premarket Gains:  $BFT, $STPK, $KPTI, $LPTX, $GHIV, $APPN, $OSMT, $COCP, $BLU, $MYOV, $THBR, $MVIS, $AMRS, $KNTE.\nHappy Trading Today! \xf0\x9f\x98\x83\xf0\x9f\x98\x80\xf0\x9f\x98\x86\xe2\x98\xba\xef\xb8\x8f'"
2020-12-29,b'RT @IPODave: $KNTE price targets coming in between $48-$60.  See if it can close over its highs into EOY'
2020-12-29,b'Another recent IPO looking like a nice entry area $KNTE https://t.co/1EHC8A09af'
2020-12-29,"b'RT @semodough: GS $KNTE candidates are pre-IND stage, BRAF and FGFR are validated targets. see a relatively straightforward clinical pathwa\xe2\x80\xa6'"
2020-12-29,"b""@semodough dough, maybe but let's not forget GS took ~41% of the off'g so a lot of skin in this game for clients. Fact that $KNTE popped and has struggled to hold strong opening lays predicate for sell-side premise. A lot of back-and-fill needed to justify valuation for, as u say, pre-IND"""
2020-12-29,"b'GS $KNTE candidates are pre-IND stage, BRAF and FGFR are validated targets. see a relatively straightforward clinical pathway and believe that KNTE can make rapid progress through the clinic to the regulatory stage over the next few years'"
2020-12-28,b'$KNTE $IBB - Kinnate Biopharma earns bulls as IPO quiet period ends https://t.co/e5UpgBrka0'
2020-12-28,"b'$KNTE latest ratings on 2020-12-28 at Stock Target Advisor https://t.co/AyDto6TCK2 : Wedbush (Initiated by), Piper Sandler (Initiated by), Goldman Sachs (Initiated by), SVB Leerink (Initiated by)'"
2020-12-28,b'$KNTE Why SVB Leerink Is Bullish On Kinnate Biopharma $KNTE https://t.co/rAl0ey12Pc # via @benzinga'
2020-12-28,b'Why These 4 Health Care Stocks Are Moving Today $AYTU $KNTE $MYOV https://t.co/CYSCpNkVqL via @benzinga'
2020-12-28,b'RT @FrontPageArmy: Gourmet Provisions International Corp. $GMPR Announces Final Negotiations to Launch a line of Custom Gourmet Psychedelic\xe2\x80\xa6'
2020-12-28,b'$KNTE  Why SVB Leerink Is Bullish On Kinnate Biopharma\n\nhttps://t.co/PDQKuhPF0L'
2020-12-28,b'Gourmet Provisions International Corp. $GMPR Announces Final Negotiations to Launch a line of Custom Gourmet Psychedelic Edibles &amp; Expansion of CBD Line of Products https://t.co/c9XAz7QHQl @frontpagestocks \n\n$LOAK $AMST $CLSK $STPK $OCGN $IEC $LCA $VRME $ZKIN $CLNE $KNTE $PAE https://t.co/EmUZyZ7fGg'
2020-12-28,b'Gourmet Provisions International Corp. $GMPR Announces Final Negotiations to Launch a line of Custom Gourmet Psychedelic Edibles &amp; Expansion of CBD Line of Products https://t.co/Is0xUHafki @frontpagestocks \n\n$LOAK $AMST $CLSK $STPK $OCGN $IEC $LCA $VRME $ZKIN $CLNE $KNTE $PAE https://t.co/WQdXsoHKE0'
2020-12-28,b'Why SVB Leerink Is Bullish On Kinnate Biopharma $KNTE https://t.co/jfuuaSOQ1m via @benzinga'
2020-12-28,b'RT @WayoftheMaster7: $QS $ADBE $MAS $TTCF $KNTE $BEAM $EH $CMBM $HELE $CLSK $QLD $AXSM $IPOD $HRTX $YEXT $LOVE $CCCC..... #TheStrat https:/\xe2\x80\xa6'
2020-12-28,"b""RT @WayoftheMaster7: Hit em if you want em! #TheStrat \n\nInside D Add's... $ALLK $ENPH $BEAM $CCCC $RUN $WMG $CSII $BE $BRBR $AOSL $SWBI $YE\xe2\x80\xa6"""
2020-12-28,"b""RT @WayoftheMaster7: Hit em if you want em! #TheStrat\n\nInside D Add's.. $SOLO $XPEL $EDIT $ETSY $SWBI $MED $SHOP $MRVI $DDOG $SITM $BNTX $S\xe2\x80\xa6"""
2020-12-28,b'$BTBT &amp; $FDMT setting up nicely....  $KNTE needs to take out todays close'
2020-12-28,"b""Kinnate initiations, Nikola target change among today's top calls on Wall Street\n$KNTE $NKLA $GM $RSG $AVGO $ALGM $NVDA $AMD $MU $NXPI $ON $QCOM $SWKS $XLNX $WDC $STX $MCHP $LRCX $ALV $AMAT $FOLD $KMX"""
2020-12-28,"b'SVB Leerink bullish on Kinnate Biopharma, initiates with an Outperform\n$KNTE'"
2020-12-28,b'A Peek Into The Markets: US Stock Futures Gain As Trump Signs $900B Covid-19 Relief Bill $AZN $BABA $KNTE https://t.co/ZnG4EaHLCH ##premarket via @benzinga'
2020-12-28,"b'$KNTE \nSVB Leerink Initiates Coverage On Kinnate Biopharma with Outperform Rating, Announces Price Target of $52\nSVB Leerink initiates coverage on Kinnate Biopharma (NASDAQ:KNTE) with a Outperform rating and announces Price Target of $52.'"
2020-12-28,"b'Analyst comments:  \n\n$KNTE +7.8% (initiated with a Buy at Goldman, among others) \n\n$AMST +6.8% (initiated with a Speculative Buy at The Benchmark Company) \n\n$PAE +1.2% (initiated with an Overweight at Morgan Stanley)'"
2020-12-28,b'Wall Street Initiates Coverage of Kinnate Biopharma $KNTE With At Least 4 Buy Ratings https://t.co/VggGo7GMh0 https://t.co/HDSUJ4nqZj'
2020-12-28,b'$KNTE (+7.9% pre) Wall Street Initiates Coverage of Kinnate Biopharma (KNTE) With At Least 4 Buy Ratings\n\nhttps://t.co/12qMp6T8aH'
2020-12-28,"b'$KNTE another one, new IPO, that could run ....\n\nhttps://t.co/YKHzQr6RWO'"
2020-12-28,"b'Wedbush Initiates Coverage On Kinnate Biopharma with Outperform Rating, Announces Price Target of $48\n\nRelated Tickers: $KNTE\nRead more at: https://t.co/EbKpZdR4q5'"
2020-12-28,b'$KNTE Piper Sandler Starts Kinnate Biopharma at Overweight PT $60 https://t.co/wlE55mq44n'
2020-12-28,b'RT @IPODave: $KNTE price targets coming in between $48-$60.  See if it can close over its highs into EOY'
2020-12-28,b'$KNTE price targets coming in between $48-$60.  See if it can close over its highs into EOY'
2020-12-28,"b'Wedbush bullish on Kinnate Biopharma, initiates with an Outperform\n$KNTE'"
2020-12-28,b'Goldman Initiated Kinnate BioPharma $KNTE with a Buy rating and price target at $48.\nhttps://t.co/f9eKKElXpU'
2020-12-28,b'A Peek Into The Markets: US Stock Futures Gain As Trump Signs $900B Covid-19 Relief Bill $AZN $BABA $KNTE  https://t.co/tnUOp2WKNo'
2020-12-28,b'$KNTE GS out with PT $48'
2020-12-28,"b'$KNTE Piper initiates with Overweight, PT 60'"
2020-12-28,"b'$KNTE Leerink initiates with Outperform, PT 52'"
2020-12-28,b'$KNTE Wedbush initiates with Outperform'
2020-12-28,b'$KNTE #Kinnate Biopharma ... Initiating at OUTPERFORM; Its Not Too Late to Buy Kinnate: [...] https://t.co/4F59GyCoQu #equity #stocks https://t.co/tbefjHZPeP'
2020-12-28,b'A Peek Into The Markets: US Stock Futures Gain As Trump Signs $900B Covid-19 Relief Bill\n\nRelated Tickers: $AZN $BABA $KNTE $ORPH $WB\nRead more at: https://t.co/g8kyZeFKPM'
2020-12-28,b'$KNTE KINNATE BIOPHARMA INC  KNTE.O: WEDBUSH INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $48'
2020-12-28,"b'SVB Leerink Initiates Coverage On Kinnate Biopharma with Outperform Rating, Announces Price Target of $52\n\nRelated Tickers: $KNTE\nRead more at: https://t.co/hZzUu7E9Ps'"
2020-12-28,b'Kinnate Biopharma initiated with an Outperform at SVB Leerink\n$KNTE'
2020-12-28,"b'Piper Sandler Initiates Coverage On Kinnate Biopharma with Overweight Rating, Announces Price Target of $60\n\nRelated Tickers: $KNTE\nRead more at: https://t.co/kYVtXZlXeq'"
2020-12-28,"b'$KNTE GS initiates with Buy, PT 48'"
2020-12-28,b'Kinnate Biopharma initiated with an Overweight at Piper Sandler\n$KNTE'
2020-12-28,b'Kinnate Biopharma initiated with a Buy at Goldman Sachs\n$KNTE'
2020-12-28,b'Coverage begins for $KNTE tomorrow (Monday) and on Tuesday for $SEER'
2020-12-27,b'RT @AceVentrader: $INCY NDA for ruxolitinib cream in atopic dermatitis is planned for the end of 2020.\n$EYEN NDA submission for pharmacolog\xe2\x80\xa6'
2020-12-27,b'$INCY NDA for ruxolitinib cream in atopic dermatitis is planned for the end of 2020.\n$EYEN NDA submission for pharmacologic mydriasis is planned for the end of 2020.\nIPO Quiet Period Expiries: $KNTE $SEER $SGTX $SBTX'
2021-01-07,"b""$AI $CCL $CIIC $LOAK $DNMR $FSR $BFT $INAQ $KNTE $RIDE $QS $TPGY $VERU $VGAC $SPCE Called today's rally. With a united government/house/senate - if you are in renewable energy/AI/Green Recycling/Biotech/Infrastructure h... https://t.co/Cxzl0G7jxe https://t.co/h9vLARf9um"""
2021-01-07,"b""Rose Above Previous Day's High today: $CRS $EFR $MLPX $FBK $CTRA $CCL $XLE $SRCL $KNTE $KBH $MCY $MIC $PHM $HES $SMMV $MDC $TYG $USFD $IYT $FTXO ... https://t.co/TBYRpvrFqi"""
2021-01-07,b'RT @Biotech2k1: My New Top 10:\n\n1. $GBIO\n2. $CABA\n3. $TRIL\n4. $RNA\n5. $TCRR\n6. $ALXO\n7. $BPMC\n8. $FDMT\n9. $KNTE\n10. $YMAB\n\nI removed all th\xe2\x80\xa6'
2021-01-07,b'RT @Biotech2k1: My New Top 10:\n\n1. $GBIO\n2. $CABA\n3. $TRIL\n4. $RNA\n5. $TCRR\n6. $ALXO\n7. $BPMC\n8. $FDMT\n9. $KNTE\n10. $YMAB\n\nI removed all th\xe2\x80\xa6'
2021-01-07,b'RT @Biotech2k1: My New Top 10:\n\n1. $GBIO\n2. $CABA\n3. $TRIL\n4. $RNA\n5. $TCRR\n6. $ALXO\n7. $BPMC\n8. $FDMT\n9. $KNTE\n10. $YMAB\n\nI removed all th\xe2\x80\xa6'
2021-01-07,b'My New Top 10:\n\n1. $GBIO\n2. $CABA\n3. $TRIL\n4. $RNA\n5. $TCRR\n6. $ALXO\n7. $BPMC\n8. $FDMT\n9. $KNTE\n10. $YMAB\n\nI removed all the bubbly fairy tale stocks and built a list of potential next fairy tale stocks. All are high risk and some will most likely fail so word of caution.'
2021-01-07,b'RT @Biotech2k1: Bought a little $KNTE to fill out my core position. Now I am on hold until this biotech bubble pops. Sure I can buy more of\xe2\x80\xa6'
2021-01-07,b'RT @Biotech2k1: Bought a little $KNTE to fill out my core position. Now I am on hold until this biotech bubble pops. Sure I can buy more of\xe2\x80\xa6'
2021-01-06,b'Scan results - Hot IPO Pullback today: $ABCL $PUBM $SEER $AI $KNTE $AIRC $CERT $SCPS ... https://t.co/mYul9uIKow'
2021-01-06,b'@HulkCapitalPro Still holding $KNTE?'
